AllTrak Raises INR 4.2Cr in Pre-Series A Funding Round Led by Inflection Point Ventures for Healthcare Technology Expansion

Healthcare technology and logistics platform, AllTrak, secures INR 4.2Cr in a pre-series A round led by Inflection Point Ventures. The funds will fuel team expansion, technology enhancements, and the growth of logistics operations across multiple Indian cities. Founded in 2021, AllTrak's B2B HealthTech solutions, including a Technology SaaS platform and pan India shared logistics network, empower diagnostic companies for efficient patient service. With a technology platform monitoring 7 Lac patient samples monthly and operations in over 50 cities, AllTrak aims to revolutionize healthcare with the support of IPV investors.

Dec 7, 2023 - 11:04
Dec 7, 2023 - 11:05
 0
AllTrak Raises INR 4.2Cr in Pre-Series A Funding Round Led by Inflection Point Ventures for Healthcare Technology Expansion
AllTrak

AllTrak, the innovative healthcare technology and logistics platform, has successfully raised INR 4.2Cr in a pre-series A funding round led by Inflection Point Ventures. This strategic infusion of funds is earmarked for key initiatives, including team expansion, technology enhancements, and the expansion of logistics operations across multiple cities in India.

Founded in 2021 by healthcare industry veterans Amit Gupta and Tarun Sharma, AllTrak is a B2B HealthTech company that provides end-to-end solutions to diagnostic companies. The company's comprehensive ecosystem comprises a Technology SaaS platform, a pan India shared logistics network, and a phlebotomist network, empowering healthcare companies to efficiently serve their patients.

Amit Gupta, AllTrak's Founder and CEO, brings over 20 years of experience in building technology platforms, having worked with renowned companies such as General Motors, EDS, Computer Associates, ABN Amro, and Capgemini. Co-founder Tarun Sharma, with 15+ years of work experience in healthcare operations, has managed large-scale healthcare operations across India.

Vikram Ramasubramanian, Partner at Inflection Point Ventures, emphasized the critical role played by AllTrak in overcoming logistical challenges in the wake of the Covid-19 pandemic. He noted that AllTrak's integrated approach contributes to more effective and streamlined transportation and tracking of diagnostic healthcare samples, ultimately benefiting patient care and treatment planning.

AllTrak's technology platform currently tracks and monitors an impressive 7 Lac patient samples per month. The tech-enabled logistics network facilitates seamless healthcare operations in over 50 cities, including major metropolitan areas and tier 2 and tier 3 cities. With 5000+ registered healthcare professionals and a network of 10,500+ pickup locations/centres, AllTrak's unique technology offering is trusted by some of India's top 10 healthcare companies.

Speaking about the company's vision, Amit Gupta stated, "With India's GDP set to reach $5T by Y2027 and $10T by Y2035, healthcare is poised to be a crucial sector for growth. We aim to capitalize on this opportunity by building and offering a robust ecosystem for healthcare companies to thrive." He expressed gratitude for the support from IPV investors, highlighting their role in helping AllTrak realize its vision of revolutionizing the healthcare industry.

According to a report by Polaris Market Research in March 2023, the Indian diagnostic services market is projected to reach USD 43.57 billion by FY32, emphasizing the immense potential in the sector.

About AllTrak: AllTrak is a B2B HealthTech startup focused on building an ecosystem for healthcare companies, providing a healthcare technology SaaS platform and a logistics network at a pan-India level.

About Inflection Point Ventures & Physis Capital: Inflection Point Ventures (IPV) is an angel investing platform with over 9600 CXOs, HNIs, and Professionals collectively investing in startups. The firm supports new-age entrepreneurs by providing monetary and experiential capital, connecting them with a diverse group of investors. IPV recently announced the launch of a $50 million CAT 2 AIF, Physis Capital, aimed at investing in pre-Series A to Series B growth-stage startups.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow